The impact of 5-ARI on perioperative and functional outcomes of GreenLight PVP: an analysis of the Global GreenLight Group database
Tawfik Elsherbini1,*, David Bouhadana2,*, Iman Sadri3, David-Dan Nguyen4, Kyle W. Law5, Adel Arezki3, Claudia Deyirmendjian1, Ahmed Ibrahim5, Naeem Bhojani5, Dean S. Elterman6, Bilal Chughtai7, Franck Bruyère8, Luca Cindolo9, Giovanni Ferrari9, Carlos Vasquez-Lastra10, Tiago Borelli-Bovo11, Edgardo F. Becher12, Hannes Cash13, Maximillian Reimann14, Enrique Rijo15, Vincent Misrai16, Kevin C. Zorn5
Canadian Journal of Urology, Vol.30, No.2, pp. 11473-11479, 2023
Abstract Introduction: In this study, we sought to investigate the impact of 5-alpha reductase inhibitors (5-ARI) on the perioperative and functional outcomes of 180-Watt XPS GreenLight photovaporization of the prostate (PVP) using a large international database.
Materials and methods: Data were obtained from the Global GreenLight Group (GGG) database, which includes eight high-volume, experienced surgeons from seven international centers. All men with established benign prostatic hyperplasia (BPH) with known 5-ARI status who underwent GreenLight PVP using the XPS-180W system between 2011 and 2019 were eligible for the study. Patients were assigned to two groups based on the preoperative… More >